Cargando…

Development of a Patient-Centered Bilingual Prescription Drug Label

Research shows that prescription drug labels are often difficult for patients to understand, which contributes to medication errors and nonadherence. In this study, the authors developed and qualitatively evaluated an evidence-based bilingual prescription container label designed to improve understa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Arun, Riley, M. Brian, Boyington, Dane, Johnston, Phillip, Trochez, Karen, Jennings, Callie, Mashburn, Jennie, Kripalani, Sunil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815084/
https://www.ncbi.nlm.nih.gov/pubmed/24093345
http://dx.doi.org/10.1080/10810730.2013.825664
_version_ 1782289358959673344
author Mohan, Arun
Riley, M. Brian
Boyington, Dane
Johnston, Phillip
Trochez, Karen
Jennings, Callie
Mashburn, Jennie
Kripalani, Sunil
author_facet Mohan, Arun
Riley, M. Brian
Boyington, Dane
Johnston, Phillip
Trochez, Karen
Jennings, Callie
Mashburn, Jennie
Kripalani, Sunil
author_sort Mohan, Arun
collection PubMed
description Research shows that prescription drug labels are often difficult for patients to understand, which contributes to medication errors and nonadherence. In this study, the authors developed and qualitatively evaluated an evidence-based bilingual prescription container label designed to improve understanding. The authors developed several prototypes in English only or in English and Spanish. The labels included an image of the drug, an icon to show its purpose, and plain-language instructions presented in a 4-time-of-day table. In 5 focus groups and interviews that included 57 participants, patients and pharmacists critically reviewed the designs and compared them with traditional medication labels and reformatted labels without illustrations. Patients strongly preferred labels that grouped patient-relevant content, highlighted key information, and included drug indication icons. They also preferred having the 4-time-of-day table and plain-language text instructions as opposed to either one alone. Patients preferred having pertinent warnings on the main label instead of auxiliary labels. Pharmacists and Latino patients valued having Spanish and English instructions on the label, so both parties could understand the content. The final label design adheres to the latest national- and state-level recommendations for label format and incorporates additional improvements on the basis of patient and pharmacist input. This design may serve as a prototype for improving prescription drug labeling.
format Online
Article
Text
id pubmed-3815084
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-38150842013-11-04 Development of a Patient-Centered Bilingual Prescription Drug Label Mohan, Arun Riley, M. Brian Boyington, Dane Johnston, Phillip Trochez, Karen Jennings, Callie Mashburn, Jennie Kripalani, Sunil J Health Commun Research Article Research shows that prescription drug labels are often difficult for patients to understand, which contributes to medication errors and nonadherence. In this study, the authors developed and qualitatively evaluated an evidence-based bilingual prescription container label designed to improve understanding. The authors developed several prototypes in English only or in English and Spanish. The labels included an image of the drug, an icon to show its purpose, and plain-language instructions presented in a 4-time-of-day table. In 5 focus groups and interviews that included 57 participants, patients and pharmacists critically reviewed the designs and compared them with traditional medication labels and reformatted labels without illustrations. Patients strongly preferred labels that grouped patient-relevant content, highlighted key information, and included drug indication icons. They also preferred having the 4-time-of-day table and plain-language text instructions as opposed to either one alone. Patients preferred having pertinent warnings on the main label instead of auxiliary labels. Pharmacists and Latino patients valued having Spanish and English instructions on the label, so both parties could understand the content. The final label design adheres to the latest national- and state-level recommendations for label format and incorporates additional improvements on the basis of patient and pharmacist input. This design may serve as a prototype for improving prescription drug labeling. Taylor & Francis 2013-10-04 2013-12 /pmc/articles/PMC3815084/ /pubmed/24093345 http://dx.doi.org/10.1080/10810730.2013.825664 Text en © Arun Mohan, M. Brian Riley, Dane Boyington, Phillip Johnston, Karen Trochez, Callie Jennings, Jennie Mashburn, and Sunil Kripalani http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf This is an open access article distributed under the Supplemental Terms and Conditions for iOpenAccess articles published in Taylor & Francis journals (http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mohan, Arun
Riley, M. Brian
Boyington, Dane
Johnston, Phillip
Trochez, Karen
Jennings, Callie
Mashburn, Jennie
Kripalani, Sunil
Development of a Patient-Centered Bilingual Prescription Drug Label
title Development of a Patient-Centered Bilingual Prescription Drug Label
title_full Development of a Patient-Centered Bilingual Prescription Drug Label
title_fullStr Development of a Patient-Centered Bilingual Prescription Drug Label
title_full_unstemmed Development of a Patient-Centered Bilingual Prescription Drug Label
title_short Development of a Patient-Centered Bilingual Prescription Drug Label
title_sort development of a patient-centered bilingual prescription drug label
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815084/
https://www.ncbi.nlm.nih.gov/pubmed/24093345
http://dx.doi.org/10.1080/10810730.2013.825664
work_keys_str_mv AT mohanarun developmentofapatientcenteredbilingualprescriptiondruglabel
AT rileymbrian developmentofapatientcenteredbilingualprescriptiondruglabel
AT boyingtondane developmentofapatientcenteredbilingualprescriptiondruglabel
AT johnstonphillip developmentofapatientcenteredbilingualprescriptiondruglabel
AT trochezkaren developmentofapatientcenteredbilingualprescriptiondruglabel
AT jenningscallie developmentofapatientcenteredbilingualprescriptiondruglabel
AT mashburnjennie developmentofapatientcenteredbilingualprescriptiondruglabel
AT kripalanisunil developmentofapatientcenteredbilingualprescriptiondruglabel